ReNeuron Group PLC RQE1-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 9:46 AM CEST
0.318UNCH (UNCH)
52 week range
0.29 - 1.41
Loading...
  • Open0.318
  • Day High0.318
  • Day Low0.318
  • Prev Close0.326
  • 52 Week High1.41
  • 52 Week High Date06/22/21
  • 52 Week Low0.29
  • 52 Week Low Date03/10/22

Key Stats

  • Market Cap19.96M
  • Shares Out56.94M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-63.66

KEY STATS

  • Open0.318
  • Day High0.318
  • Day Low0.318
  • Prev Close0.326
  • 52 Week High1.41
  • 52 Week High Date06/22/21
  • 52 Week Low0.29
  • 52 Week Low Date03/10/22
  • Market Cap19.96M
  • Shares Out56.94M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-63.66

RATIOS/PROFITABILITY

  • EPS (TTM)-0.22
  • P/E (TTM)-1.45
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ReNeuron Group PLC

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
ReNeuron Group plc is a United Kingdom-based Stem Cell and Exosome Technologies company that utilizes its stem cell technologies to develop treatments for disease with unmet needs. The Company’s stem cell derived Exosome Technology platform offers a delivery mechanism for a variety of payloads, such as small interfering Ribonucleic Acid (siRNA), messenger RNA (mRNA), proteins, small molecules and genes. The Company has two clinical-stage stem cell therapy candidate assets, a...
Iain Ross
Non-Executive Chairman of the Board
Catherine Isted
Chief Financial Officer, Executive Director
Shaun Stapleton
Vice President Regulatory Affairs and Pharmacovigilance
Randolph Corteling Ph.D.
Vice President - Research
Address
Pencoed Business Park
Bridgend
CF35 5HY
United Kingdom